Prevalence, correlates, and network analysis of depression and its association with quality of life in survivors with myocardial infarction during the COVID-19 pandemic

Lin, Yuanhua; Bai, Wei; Liu, Honghong; Li, Zhizhong; Gao, Zhen; Han, Tao; Ren, Hongye; Ng, Chee H.; Xiang, Yu Tao

doi:10.1016/j.jad.2023.05.086

Cited by 2 publications

(1 citation statement)

References 58 publications

(67 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In addition, possible job loss, trauma, or health threats due to the pandemic and imposed curfews or social distancing may have caused psychological stress and exacerbated existing mental health problems that could interact with cardiovascular disease [21]. It was also found that the COVID-19 pandemic impacted the outcomes of acute coronary syndromes [22] and the quality of life in AMI survivors [23]. Thus, this study aimed to evaluate the frequency of fatigue and depression in post-AMI patients during the COVID-19 pandemic and to investigate the associations between fatigue, depression and HRQoL.…”

Section: Introductionmentioning

confidence: 99%

Fatigue, Depression and Health-Related Quality of Life in Patients with Post-Myocardial Infarction during the COVID-19 Pandemic: Results from the Augsburg Myocardial Infarction Registry

Meisinger,

Kirchberger,

Raake

et al. 2023

JCM

View full text Add to dashboard Cite

The interplay between fatigue and depression and their association with health-related quality of life (HRQoL) after acute myocardial infarction (AMI) has received little attention during the COVID-19 pandemic. Therefore, this study evaluated the frequency of fatigue and depression in post-AMI patients during the COVID-19 pandemic and investigated the cross-sectional associations between fatigue, depression and HRQoL. Methods: The analysis was based on population-based Myocardial Infarction Registry Augsburg data. All survivors of AMI between 1 June 2020 and 15 September 2021 were included (n = 882) and received a postal questionnaire containing questions about fatigue (Fatigue Assessment Scale), depression (Patient Health Questionnaire), and HRQoL (MacNew Heart Disease HRQoL questionnaire) on 17 November 2021. The questionnaire was returned by 592 patients (67.1%), and 574 participants could be included in the analysis. Multivariable linear regression models were performed to investigate the associations between fatigue and depression (both exposures) and HRQoL (outcome). Results: Altogether, 273 (47.6%) participants met the criteria for the presence of fatigue, about 16% showed signs of moderate to severe depression. Both fatigue and depression were significantly associated with a decreased HRQoL (total score and emotional, social, and physical subscales; all p-values < 0.0001). In particular, a combined occurrence of fatigue and depression was associated with a significantly reduced HRQoL. Conclusions: It seems necessary to screen post-MI patients for the presence of fatigue and depression in clinical practice on a routine basis to provide them with adequate support and treatment and thus also to improve their HRQoL.

show abstract

Section: Introductionmentioning

confidence: 99%